A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis
Status:
Completed
Trial end date:
2017-12-05
Target enrollment:
Participant gender:
Summary
This is a dose escalation study to test the safety, tolerability and preliminary efficacy of
ASN002 in people with moderate to severe atopic dermatitis (AD).